1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pitavastatin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with pitavastatin in 1 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (pitavastatin)	Trials (pitavastatin)	Recent Studies (post-2010) (pitavastatin)
9,156	187	552	730	192	450

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirata, K; Ishida, T; Miyamoto-Sasaki, M; Monguchi, T; Mori, K; Nakajima, H; Toh, R; Yasuda, T	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pitavastatin

Article	Year
Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients. Journal of atherosclerosis and thrombosis, 2013, Volume: 20, Issue:9 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Antioxidants; Aryldialkylphosphatase; Atherosclerosis; Cholesterol; Cholesterol, HDL; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Activating Factor; Polyethylene Glycols; Quinolines	2013

Article

Year

Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients.

Journal of atherosclerosis and thrombosis, 2013, Volume: 20, Issue:9

Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Antioxidants; Aryldialkylphosphatase; Atherosclerosis; Cholesterol; Cholesterol, HDL; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Activating Factor; Polyethylene Glycols; Quinolines

2013